Multiple 'Omics'-Analysis Reveals the Role of Prostaglandin E2 in Hirschsprung's Disease
Weibing Tang,Minjian Chen,Xuejiang Guo,Kun Zhou,Zechao Wen,Fengli Liu,Xiang Liu,Xiaohua Mao,Xiaowei He,Weiyue Hu,Xian Sun,Junwei Tang,Hongxing Li,Richard Allen I. I. I. I. White,Wei Lv,Pin Wang,Bo Hang,Rongli Sun,Xinru Wang,Yankai Xia
DOI: https://doi.org/10.1016/j.freeradbiomed.2020.12.456
2020-01-01
Journal of Glycomics & Lipidomics
Abstract:The etiology and pathogenesis of Hirschsprung's disease (HSCR) remain largely unknown. We examined colon tissues from three independent populations with a combined analysis of metabolomics, transcriptomics and proteomics to understand HSCR pathogenesis, according to which mouse model was used to examine prostaglandin E2 (PGE2) induced clinical presentation of HSCR. SH-SY5Y and SK-N-BE(2) cell lines were studied for PGE2 inhibited cell migration through EP2. Our integrated multiple 'omics'-analysis suggests that the levels of PGE2, the expression of the gene encoding PGE2 receptor (EP2), and PGE2 synthesis enzyme genes (PTGS1 and PTGES) increased in HSCR colon tissues, together with a decreased synthesis of PGE2-related byproducts. In vivo, the pregnant mice treated with PGE2 gave birth to offspring with the decrease of ganglion cells in their colon and gut function. In in vitro study, when EP2 was blocked, the PGE2-inhibited cell migration was recovered. Our study identified a novel pathway highlighting the link between expression of PTGS1 and PTGES, levels of PGE2, expression of PTGER2, and neural crest cell migration in HSCR, providing a novel strategy for future diagnosis and prevention of HSCR.